.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Merck
Daiichi Sankyo
Citi
Dow
Cantor Fitzgerald
Fish and Richardson
QuintilesIMS
AstraZeneca
UBS

Generated: December 18, 2017

DrugPatentWatch Database Preview

CARDIZEM SR Drug Profile

« Back to Dashboard

When do Cardizem Sr patents expire, and when can generic versions of Cardizem Sr launch?

Cardizem Sr is a drug marketed by Biovail and is included in one NDA.

The generic ingredient in CARDIZEM SR is diltiazem hydrochloride. There are twenty-six drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the diltiazem hydrochloride profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
BiovailCARDIZEM SRdiltiazem hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL019471-001Jan 23, 1989DISCNYesNo► Subscribe► Subscribe► Subscribe
BiovailCARDIZEM SRdiltiazem hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL019471-004Jan 23, 1989DISCNYesNo► Subscribe► Subscribe► Subscribe
BiovailCARDIZEM SRdiltiazem hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL019471-002Jan 23, 1989DISCNYesNo► Subscribe► Subscribe► Subscribe
BiovailCARDIZEM SRdiltiazem hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL019471-003Jan 23, 1989DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: CARDIZEM SR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
BiovailCARDIZEM SRdiltiazem hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL019471-001Jan 23, 1989► Subscribe► Subscribe
BiovailCARDIZEM SRdiltiazem hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL019471-004Jan 23, 1989► Subscribe► Subscribe
BiovailCARDIZEM SRdiltiazem hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL019471-003Jan 23, 1989► Subscribe► Subscribe
BiovailCARDIZEM SRdiltiazem hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL019471-002Jan 23, 1989► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Covington
QuintilesIMS
Cipla
Argus Health
Federal Trade Commission
Fuji
Express Scripts
Daiichi Sankyo
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot